Literature DB >> 7634615

Facilitation and suppression of bone metastasis.

G R Mundy1, T Yoneda.   

Abstract

Most patients with cancer die because the cancer metastasizes to other organs. Bone is 1 of the 3 most common sites of tumor metastasis, and is a catastrophic complication of cancer, because it is associated not only with intractable pain, but also with other morbidity that usually hastens an uncomfortable death. Despite its importance, to date no specific therapies to prevent this complication of cancer or treat it once it occurs have been demonstrated. In this article, current understanding of the processes involved in the pathophysiology of bone metastasis will be reviewed, and approaches aimed at preventing the development of a bone metastasis and treating bone metastasis once it has occurred will be discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634615

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  11 in total

1.  Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells.

Authors:  Xiaojia Chen; Jia Lu; Yuhua Ji; An Hong; Qiuling Xie
Journal:  Tumour Biol       Date:  2013-09-12

2.  Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.

Authors:  W C Duivenvoorden; H W Hirte; G Singh
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

3.  LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.

Authors:  E W Thompson; V Sung; M Lavigne; K Baumann; N Azumi; A D Aaron; R Clarke
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

Review 4.  Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Authors:  R M Hoffman
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  Local Suppression Effect of Paclitaxel-Impregnated Hydroxyapatite/Collagen on Breast Cancer Bone Metastasis in a Rat Model.

Authors:  Rempei Matsumoto; Toshitaka Yoshii; Satoru Egawa; Motonori Hashimoto; Takashi Hirai; Hiroyuki Inose; Yoto Oh; Koji Fujita; Atsushi Okawa; Shinichi Sotome
Journal:  Spine Surg Relat Res       Date:  2021-12-27

6.  Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.

Authors:  Alysia N Lozano-Ondoua; Katherine E Hanlon; Ashley M Symons-Liguori; Tally M Largent-Milnes; Josh J Havelin; Henry L Ferland; Anupama Chandramouli; Mabel Owusu-Ankomah; Tijana Nikolich-Zugich; Aaron P Bloom; Juan Miguel Jimenez-Andrade; Tamara King; Frank Porreca; Mark A Nelson; Patrick W Mantyh; Todd W Vanderah
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

7.  Imaging of spinal metastatic disease.

Authors:  Lubdha M Shah; Karen L Salzman
Journal:  Int J Surg Oncol       Date:  2011-11-03

8.  Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.

Authors:  Hong Zhang; Dominique M Lund; Haley A Ciccone; William D Staatz; Mohab M Ibrahim; Tally M Largent-Milnes; Herbert H Seltzman; Igor Spigelman; Todd W Vanderah
Journal:  Pain       Date:  2018-09       Impact factor: 7.926

9.  Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.

Authors:  Teri L Larkins; Marchele Nowell; Shailesh Singh; Gary L Sanford
Journal:  BMC Cancer       Date:  2006-07-10       Impact factor: 4.430

Review 10.  Development of bisphosphonates.

Authors:  Herbert Fleisch
Journal:  Breast Cancer Res       Date:  2001-11-30       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.